Delivery Order SPE2DB20D1109-SPE2DB22FQ04F
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $8,550.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, is a major...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract, which has a potential value of $2,838.72, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this award, which is not set aside for any small business or disadvantaged business designations. In...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication. The contract is a Delivery Order with a Firm Fixed Price, with an ultimate completion date of September 27, 2024 and a ceiling value of $12,552.84. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office Division, which is registered...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product - VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. This contract has a potential value of $7,125.13 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,128.68 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication, with a completion date of February 1, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The contract has a potential value of $10,598.71 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The $1,491.76 order is part of Amerisourcebergen's existing indefinite delivery contract to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp, as the prime contractor, has a history of delivering a range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,056.08 firm-fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of May 18, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,419.36 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This award is part of a broader indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00, to deliver a wide range of pharmaceuticals and medical supplies in support of the Department of Defense's military...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FQ04FDelivery Order
The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract has a ceiling value of $1,921.41 and is a Firm Fixed Price delivery order with a completion date of September 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) until June 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/8/22 |